Clinical trial · Observational
Prevalence of Delayed Chemotherapy Associated Nausea
Delayed Chemotherapy-induced Nausea: A Multi-center Prevalence Survey in Adult Oncology Patients in Clinical Practice
NCT04342780CI-TRIAL-00076273CINratecompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the prevalence of delayed chemotherapy induced nausea in adult oncology patients in real clinical practice of day clinics.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapy-induced Nausea and Vomiting | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- delayed Nausea
- timeFrame
- Each patient: each days for 5 days after chemotherapy; recruitment: six weeks
- description
- nausea that occurs 24 hours to 5 days after chemotherapy (100mm VAS in diary)
Secondary outcomes (6)
- measure
- acute nausea
- timeFrame
- Each patient: at day of chemotherapy at discharge from dayclinic; recruitment: six weeks
- description
- nausea that occurs within 24 hours of chemotherapy (100mm VAS in diary)
- measure
- acute and delayed vomiting
- timeFrame
- Each patient: each day for 5 days after chemotherapy; recruitment: six weeks
- description
- vomiting that occurs within 5 days of chemotherapy (100mm VAS in diary)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * first day of chemotherapy of a new cycle (any cycle) * speak and write German * sign the consent forms Exclusion Criteria: * cognitive or linguistic impairments that would significantly impede consent or participation (as assessed by the nurses in charge) * accompanying radiotherapy; * pre-existing nausea within three days before the start of the first chemotherapy in this cycle; and * prior participation in CINrate (each person participates only once)
References
Publications (1)
- DERIVEDEngst R, Glaus A, Moessner U, Ott S, Koller A. Delayed Chemotherapy-Induced Nausea - A Nurse-Led International Observational Study in Routine Oncology Practice (CINrate). SAGE Open Nurs. 2025 Dec 2;11:23779608251398116. doi: 10.1177/23779608251398116. eCollection 2025 Jan-Dec. PMID 41356791